Study seeks best way to monitor heart health during breast cancer therapy
NCT ID NCT02696707
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 23 times
Summary
This study looked at 200 women with early-stage breast cancer who were taking trastuzumab, a drug that can sometimes harm the heart. Researchers compared two different schedules for checking heart function to see which one works better. The goal was to find the safest and most effective way to monitor heart health during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Southlake Regional Health Centre
Newmarket, Ontario, L3Y 2P9, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K2H 8L6, Canada
-
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
Conditions
Explore the condition pages connected to this study.